| Primary |
| Product Used For Unknown Indication |
22.6% |
| Schizophrenia |
12.0% |
| Drug Use For Unknown Indication |
11.3% |
| Psychotic Disorder |
8.1% |
| Agitation |
7.8% |
| Schizophrenia, Paranoid Type |
7.4% |
| Drug Exposure During Pregnancy |
4.1% |
| Bipolar Disorder |
4.0% |
| Hypertension |
3.2% |
| Schizoaffective Disorder |
2.9% |
| Maternal Exposure Before Pregnancy |
2.4% |
| Mania |
2.2% |
| Suicide Attempt |
2.1% |
| Hyperlipidaemia |
1.8% |
| Bipolar I Disorder |
1.7% |
| Diabetes Mellitus |
1.7% |
| Depression |
1.5% |
| Dementia |
1.1% |
| Delirium |
1.0% |
| Schizophrenia, Disorganised Type |
0.9% |
|
| Weight Increased |
54.5% |
| Neuroleptic Malignant Syndrome |
4.7% |
| Tremor |
4.7% |
| Extrapyramidal Disorder |
4.4% |
| Electrocardiogram Qt Prolonged |
3.3% |
| Pulmonary Embolism |
2.9% |
| Tardive Dyskinesia |
2.5% |
| Toxicity To Various Agents |
2.4% |
| Cardiac Arrest |
2.3% |
| Rhabdomyolysis |
2.1% |
| Weight Decreased |
2.0% |
| Cognitive Disorder |
1.9% |
| Dystonia |
1.8% |
| Torsade De Pointes |
1.8% |
| Sedation |
1.5% |
| Treatment Noncompliance |
1.5% |
| Vomiting |
1.5% |
| Death |
1.4% |
| Drug Interaction |
1.4% |
| Drug Toxicity |
1.4% |
|
| Secondary |
| Product Used For Unknown Indication |
25.6% |
| Schizophrenia |
16.9% |
| Drug Use For Unknown Indication |
14.6% |
| Agitation |
6.2% |
| Psychotic Disorder |
5.1% |
| Schizophrenia, Paranoid Type |
3.7% |
| Insomnia |
3.2% |
| Bipolar Disorder |
3.2% |
| Drug Abuse |
2.9% |
| Depression |
2.8% |
| Pain |
2.7% |
| Schizoaffective Disorder |
1.7% |
| Mental Disorder |
1.6% |
| Alcoholic Psychosis |
1.5% |
| Delirium |
1.5% |
| Sedation |
1.4% |
| Hallucination, Auditory |
1.4% |
| Bipolar I Disorder |
1.4% |
| Irritability |
1.3% |
| Mania |
1.2% |
|
| Neuroleptic Malignant Syndrome |
18.7% |
| Completed Suicide |
10.5% |
| Weight Increased |
9.2% |
| White Blood Cell Count Increased |
4.6% |
| Psychotic Disorder |
4.3% |
| Death |
4.0% |
| Somnolence |
4.0% |
| Rhabdomyolysis |
3.9% |
| Speech Disorder |
3.9% |
| Treatment Noncompliance |
3.9% |
| Pulmonary Embolism |
3.8% |
| Pyrexia |
3.6% |
| Schizophrenia |
3.5% |
| Extrapyramidal Disorder |
3.4% |
| Unresponsive To Stimuli |
3.4% |
| Toxicity To Various Agents |
3.3% |
| Vomiting |
3.1% |
| Torsade De Pointes |
3.0% |
| Tremor |
3.0% |
| Sedation |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.8% |
| Drug Use For Unknown Indication |
21.2% |
| Schizophrenia |
12.2% |
| Prophylaxis |
4.8% |
| Depression |
4.1% |
| Pain |
4.1% |
| Hypertension |
3.6% |
| Psychotic Disorder |
2.9% |
| Constipation |
2.8% |
| Schizophrenia, Paranoid Type |
2.7% |
| Nausea |
2.6% |
| Insomnia |
2.5% |
| Agitation |
2.3% |
| Bipolar Disorder |
2.3% |
| Anxiety |
2.0% |
| Multiple Myeloma |
1.9% |
| Schizoaffective Disorder |
1.8% |
| Hiv Infection |
1.6% |
| Diabetes Mellitus |
1.5% |
| Sedation |
1.2% |
|
| Weight Increased |
9.0% |
| Vomiting |
8.8% |
| White Blood Cell Count Decreased |
7.5% |
| Weight Decreased |
6.8% |
| White Blood Cell Count Increased |
6.5% |
| Death |
5.4% |
| Thrombocytopenia |
5.2% |
| Type 2 Diabetes Mellitus |
4.9% |
| Pyrexia |
4.8% |
| Psychotic Disorder |
4.7% |
| Granulocytopenia |
4.4% |
| Somnolence |
4.4% |
| Rhabdomyolysis |
4.1% |
| Leukopenia |
3.6% |
| Pneumonia |
3.5% |
| Renal Failure |
3.5% |
| Renal Failure Acute |
3.4% |
| Sepsis |
3.3% |
| Tremor |
3.3% |
| Respiratory Failure |
3.0% |
|
| Interacting |
| Product Used For Unknown Indication |
24.4% |
| Schizophrenia |
13.1% |
| Drug Use For Unknown Indication |
11.4% |
| Anaesthesia |
6.7% |
| Psychotic Disorder |
4.5% |
| Restless Legs Syndrome |
4.5% |
| Depression |
4.3% |
| Antiemetic Supportive Care |
4.1% |
| Bipolar Disorder |
3.4% |
| Hypertension |
3.2% |
| Pain |
2.8% |
| Abnormal Behaviour |
2.2% |
| Cardiac Disorder |
2.2% |
| Constipation |
2.2% |
| Insomnia |
2.2% |
| Schizophrenia, Paranoid Type |
2.2% |
| Prophylaxis |
2.1% |
| Antidepressant Therapy |
1.5% |
| Paranoia |
1.5% |
| Staphylococcal Infection |
1.5% |
|
| Drug Interaction |
35.2% |
| Hypertension |
9.1% |
| Renal Failure |
6.8% |
| Rhabdomyolysis |
5.7% |
| Sudden Death |
5.7% |
| Off Label Use |
3.4% |
| Psychotic Disorder |
3.4% |
| Tachycardia |
3.4% |
| Akathisia |
2.3% |
| Extrapyramidal Disorder |
2.3% |
| Hyperprolactinaemia |
2.3% |
| Nervous System Disorder |
2.3% |
| Neurological Examination Abnormal |
2.3% |
| Parkinsonism |
2.3% |
| Respiratory Distress |
2.3% |
| Soliloquy |
2.3% |
| Syncope |
2.3% |
| Tachyphrenia |
2.3% |
| Weight Decreased |
2.3% |
| White Blood Cell Count Decreased |
2.3% |
|
